Efficacy and tolerability of the American Heartworm Society therapeutic protocol in dogs affected by heartworm disease without caval syndrome.
Journal
The Journal of small animal practice
ISSN: 1748-5827
Titre abrégé: J Small Anim Pract
Pays: England
ID NLM: 0165053
Informations de publication
Date de publication:
27 Oct 2023
27 Oct 2023
Historique:
revised:
09
09
2023
received:
12
05
2023
accepted:
01
10
2023
medline:
27
10
2023
pubmed:
27
10
2023
entrez:
27
10
2023
Statut:
aheadofprint
Résumé
The American Heartworm Society medical protocol represents the current standard of therapy for canine heartworm disease without caval syndrome. However, data on the tolerability of this protocol are limited. This study aimed to describe efficacy and prevalence of possible treatment-related side effects in dogs with heartworm disease treated using the American Heartworm Society protocol. For this retrospective multi-centre cohort study, dogs diagnosed with classes 1 to 3 heartworm disease that completed the American Heartworm Society medical protocol were searched in four medical databases. Demographic, clinical, diagnostic, therapeutic and outcome data, including the number and type of possible treatment-related side effects, were retrieved. Thirty-five dogs were included. The median age and bodyweight were 6 years (1 to 13 years) and 17.3 kg (4.9 to 50 kg), respectively. Heartworm disease was classified as classes 1, 2 and 3 in 20 of 35, 11 of 35 and four of 35 dogs, respectively. In addition to the therapeutic recommendations of the American Heartworm Society, eight of 35 dogs underwent sedation to favour melarsomine administration, and 30 of 35 received ice at the injection site. After adulticide therapy, all dogs were hospitalised with cage rest [median time 12 hours (6 to 48 hours)]. All dogs survived the treatment. All dogs with long-term follow-up (32/35) became negative. Furthermore, treatment-related side effects were rare, mild and rapidly recovered without the need for supporting therapies; these included depression/lethargy (4/35 dogs), cough (2/35 dogs) and lameness, pain and gastrointestinal signs (1/35 dog each). The American Heartworm Society medical protocol is efficient and safe in dogs with classes 1 to 3 heartworm disease.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023 The Authors. Journal of Small Animal Practice published by John Wiley & Sons Ltd on behalf of British Small Animal Veterinary Association.
Références
Arita, N., Yamane, I. & Takemura, N. (2003) Comparison of canine heartworm removal rates using flexible alligator forceps guided by transesophageal echocardiography and fluoroscopy. Journal of Veterinary Medical Science, 65, 259-261.
Atkins, C. (2017) Canine and feline heartworm disease. In: Ettinger, S.J., Feldman, E.C. & Côté, E. (Eds.) Textbook of veterinary internal medicine, 8th edition. St. Louis, MO: Elsevier, pp. 1316-1344.
Bové, C.M., Gordon, S.G., Saunders, A.B., Miller, M.W., Roland, R.M., Achen, S.E. et al. (2010) Outcome of minimally invasive surgical treatment of heartworm caval syndrome in dogs: 42 cases (1999-2007). Journal of the American Veterinary Medical Association, 236, 187-192.
Bowman, D.D. (2012) Heartworms, macrocyclic lactones, and the specter of resistance to prevention in the United States. Parasites & Vectors, 5, 138.
Case, J.L., Tanner, P.A., Keister, D.M., Meo, N., Soll, M. & Knight, D. (1995) A clinical field trial of melarsomine dihydrochloride (RM340) in dogs with severe (class 3) heartworm disease. In: Proceedings of the 1995 Heartworm Symposium. Auburn, AL: American Heartworm Society, pp. 243-250.
Cavaliere, L., Romito, G., Domenech, O. & Venco, L. (2017) Heartworm removal guided by transesophageal echocardiography in a dog with naturally acquired caval syndrome. Journal of the American Animal Hospital Association, 53, 96-100.
Dillon, A.R., Brawner, W.R. & Hanrahan, L. (1995) Influence of number of parasites and exercise on the severity of heartworm disease in dogs. In: Proceedings of the 1995 Heartworm Symposium. Auburn, AL: American Heartworm Society, p. 113.
Dzimianski, M.T., Mccall, J.W., Steffens, W.L. et al. (2001) The safety of selamectin in heartworm infected dogs and its effect on adult worms and microfilariae. In: Seward, L. (Ed.) Proceedings of the 2001 American Heartworm Symposium. Batavia, IL: American Heartworm Society, pp. 135-140.
El-Deen, D.S. & Youssef, N.F.A. (2018) The effect of cryotherapy application before versus after subcutaneous anticoagulant injection on pain intensity and hematoma formation: a quasi-experimental design. International Journal of Nursing Sciences, 5, 223-229.
European Scientific Consensus Companion Animal Parasites. (2023) Control of vector-borne diseases in dogs and cats. Available at: https://www.esccap.org/uploads/docs/5y4xn3fr_0775_ESCCAP_Guideline_GL5_20221228_1p.pdf [Accessed 5th May 2023]
Hettlich, B.F., Ryan, K., Bergman, R.L., Marks, S.L., Lewis, B.C., Bahr, A. et al. (2003) Neurologic complications after melarsomine dihydrochloride treatment for Dirofilaria immitis in three dogs. Journal of the American Veterinary Medical Association, 223, 1456-1461.
Hoskins, J.D., Hribernik, T.N. & Kearney, M.T. (1985) Complications following thiacetarsamide sodium therapy in Louisiana dogs with naturally-occurring heartworm disease. The Cornell Veterinarian, 75, 531-539.
Jacobson, L.S. & DiGangi, B.A. (2021) An accessible alternative to melarsomine: “Moxi-Doxy” for treatment of adult heartworm infection in dogs. Frontiers in Veterinary Science, 8, 702018.
Keister, D.M., Dzimianski, M.T., McTier, T.L., McCall, J.W. & Bown, J. (1992) Dose selection and confirmation of RM 340, a new filaricide for the treatment of dogs with immature and mature Dirofilaria immitis. In: Proceedings of the 1992 American Heartworm Synposium. Batavia, IL: American Heartworm Society, pp. 241-247.
Ku, T.N. (2017) Investigating management choices for canine heartworm disease in northern Mississippi. Parasites & Vectors, 10, 474.
Maxwell, E., Ryan, K., Reynolds, C. & Pariaut, R. (2014) Outcome of a heartworm treatment protocol in dogs presenting to Louisiana State University from 2008 to 2011: 50 cases. Veterinary Parasitology, 206, 71-77.
McCall, J.W., Roberts, R.E., Suakornjej, M.S. et al. (2001) Further evidence of clinical prophylactic (reach-back) and adulticidal activity of monthly administration of ivermectin and pyrantel pamoate in dogs experimentally infected with heartworms. In: Seward, L. (Ed.) Proceeedings of the 2001 American Heartworm Symposium. Batavia, IL: American Heartworm Society, pp. 189-200.
Mendoza-Roldan, J., Benelli, G., Panarese, R., Iatta, R., Furlanello, T., Beugnet, F. et al. (2020) Leishmania infantum and Dirofilaria immitis infections in Italy, 2009-2019: changing distribution patterns. Parasites & Vectors, 13, 193.
Moore, S.A., Mariani, C.L., Van Wettere, A. & Borst, L.B. (2013) Chronic compressive myelopathy and progressive neurologic signs associated with melarsomine dihydrochloride administration in a dog. Journal of the American Animal Hospital Association, 49, 389-393.
Moorhead, A. (2018) The AHS Protocol vs. “Slow Kill”. Available at: https://www.heartwormsociety.org/veterinary-resources/veterinary-education/ahs-board-speaks-out/507-the-ahs-protocol-vs-slow-kill [Accessed 10th May 2023]
Nelson, C.T., Myrick, E.S. & Nelson, T.A. (2017) Clinical benefits of incorporating doxycycline into a canine heartworm treatment protocol. Parasites & Vectors, 10, 515.
Nelson, C.T., McCall, J.W., Jones, S. et al. (2018) Current canine guidelines for the prevention, diagnosis, and management of heartworm (Dirofilaria immitis) infection in dogs (revised 2018). American Heartworm Society. Available at: https://www.heartwormsociety.org/veterinary-resources/american-heartworm-society-guidelines [Accessed 10th May 2023]
Panarese, R., Iatta, R., Beugnet, F. & Otranto, D. (2022) Incidence of Dirofilaria immitis and Leishmania infantum infections in sheltered dogs from Southern Italy. Transboundary and Emerging Diseases, 69, 891-894.
Quandt, J. (2023) Anesthesia for the dog with heartworm disease: a brief, practical review. Parasites & Vectors, 16, 151.
Rawlings, C.A. (1986a) The pulmonary arterial response to adults Dirofilaria immitis. In: Rawlings, C.A. (Ed.) Heartworm disease in dogs and cats. Philadelphia, PA: W.B. Saunders, pp. 1-39.
Rawlings, C.A. (1986b) Radiographic and electrocardiographic diagnoses. In: Rawlings, C.A. (Ed.) Heartworm disease in dogs and cats. Philadelphia, PA: W.B. Saunders, pp. 57-90.
Rawlings, C.A., Raynaud, J.P., Lewis, R.E. & Duncan, J.R. (1993) Pulmonary thromboembolism and hypertension after thiacetarsamide vs melarsomine dihydrochloride treatment of Dirofilaria immitis infection in dogs. American Journal of Veterinary Research, 54, 920-925.
Reinero, C., Visser, L.C., Kellihan, H.B., Masseau, I., Rozanski, E., Clercx, C. et al. (2020) ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs. Journal of Veterinary Internal Medicine, 34, 549-573.
Savadelis, M.D., Ohmes, C.M., Hostetler, J.A., Settje, T.L., Zolynas, R., Dzimianski, M.T. et al. (2017) Assessment of parasitological findings in heartworm-infected beagles treated with Advantage Multi® for dogs (10% imidacloprid + 2.5% moxidectin) and doxycycline. Parasites & Vectors, 10, 245.
Travell, J. (1955) Factors affecting pain of injection. Journal of the American Medical Association, 158, 368-371.
Vezzoni, A., Gechi, C. & Raynaud, J.P. (1992) Adulticide efficacy of RM340 in dogs with mild and severe natural infections. In: Proceedings of the 1992 American Heartworm Synposium. Batavia, IL: American Heartworm Society, p. 231.
Wallis, C., Saito, E.K., Salt, C., Holcombe, L.J. & Desforges, N.G. (2021) Association of periodontal disease with breed size, breed, weight, and age in pure-bred client-owned dogs in the United States. Veterinary Journal, 275, 105717.
Yoon, W.K., Kim, Y.W., Suh, S.L., Choi, R., Lee, S.-G. & Hyun, C. (2017) Evaluation of cardiopulmonary and inflammatory markers in dogs with heartworm infection during treatment with the 2014 American Heartworm Society recommended treatment protocol. Parasites & Vectors, 10(Supplement 2), 535.